Merrimack Pharma Stock Price (NASDAQ:MACK)

Add to My Stocks
$3.33 $0.05 (1.52%) MACK stock closing price Apr 28, 2017 (Closing)
YOUR DAILY UPDATE ON
MACK
Merrimack Pharma
28 APR 2017
amigobulls logo
MACK hand_up
MACK vs S&P 500
Closing Price: Apr 28, 2017
MACK
$3.33 ( 1.52%)
S&P 500
2384.2 ( -0.19%)
MACK
52 Week Price Range
1 Year Return: -55.01%
Q4 Growth*
Excellent
Profitable ?
No
net image
2016 Q4 Net Loss
-105.2%
home image
Rating
MACK POOR
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Merrimack Pharma Snapshot Video

15 5 2

MACK Stock Details

Prev Close* : $3.28
Market Cap:
$428.27M
Day Low: $3.26
52 Week Low: $2.83
Open: $3.29
Volume: 871075
Day High: $3.33
52 Week High: $7.51
Dividend:
N/A

Latest Stock Market News

Latest Articles

Merrimack Pharma News - From Partners

MACK Stockcharts

View MACK PE ratio, PS ratio stocks charts and compare with peers.
MACK Chart
Note: Compare Merrimack Pharma stock price history with the index and industry peers.

Merrimack Pharma Valuation

PS ratio (
price to sales ratio
)
3

Merrimack Pharma Financial Ratios

Asset Turnover
2.45
Receivables Turnover
8.9

MACK Industry Peers

Company Price Change (%)
Seres Therapeutics (MCRB)9.830.17 (1.7%)
American Brivision (ABVC)20 (0%)
Baxter International (BAX)55.680.26 (0.47%)
Aduro Biotech (ADRO)9.650.05 (0.52%)
Newlink Genetics (NLNK)18.690.32 (1.74%)
Immune Pharma (IMNP)3.010.03 (1.01%)
Fibrogen (FGEN)280.05 (0.18%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MiMedx (MDXG)12.691.29 (11.32%)
Regeneron Pharma (REGN)388.4921.87 (5.97%)
Evogene (EVGN)5.360.3 (5.93%)
Chromadex (CDXC)3.110.15 (5.07%)
Sarepta Therapeutics (SRPT)36.261.54 (4.44%)
Acorda Therapeutics (ACOR)16.150.6 (3.86%)
Alkermes (ALKS)58.251.95 (3.46%)
Top gainers from Medical-Biomed-Genetics industry
* As of Apr 29, 2017
CompanyPriceChange (%)
Sorrento Therapeutics (SRNE)1.950.15 (7.14%)
Revance (RVNC)21.751.55 (6.65%)
Innoviva (INVA)11.7850.81 (6.43%)
ZIOPHARM Oncology (ZIOP)7.040.47 (6.26%)
Alder BioPharma (ALDR)20.051.3 (6.09%)
Mirati Therapeutics (MRTX)4.550.23 (4.82%)
Idera Pharma (IDRA)2.350.1 (4.08%)
Top losers from Medical-Biomed-Genetics industry
* As of Apr 29, 2017

Merrimack Pharmaceuticals Inc Stock News - Partner Headlines

Merrimack Pharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues144.27M89.25M102.75M47.78M48.92M
Net Income-151.74M-147.95M-83.29M-130.92M-91.27M
Total Operating Expense247.49M218.77M169M168.31M141.65M
view Merrimack Pharmaceuticals Inc income statement
balance sheet20162015201420132012
Total Assets81.48M234.88M158.65M192.41M148.97M
Total Liabilities332.6M418.8M260.79M235.88M155.39M
Shareholders Equity-251.12M-183.92M-102.14M-43.46M-6.42M
view Merrimack Pharmaceuticals Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-62.06M14.57M23.1M14.98M-5.99M
Net Cash From (Used By) Operating Activities-170.24M-105.35M-34.8M-95.17M-79.81M
Increase (Decrease) In Prop Plant And Equipment-3.15M-12.78M-6.03M-9.85M-3.18M
view Merrimack Pharmaceuticals Inc cashflow statement

Merrimack Pharma Stock Message Board

An investor needs to spend 3.33 to buy MACK stock, as the closing Merrimack Pharma stock price is 3.33. Stock price or share price can be used to find the total market value of a company. Merrimack Pharma market cap stands at 428.27M as of 28 Apr, 2017. Merrimack Pharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Merrimack Pharma is worth a lot, it will most likely be reflected in an inflated Merrimack Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 871075 MACK shares were traded yesterday, and Merrimack Pharma stock chart shows that the MACK stock quote hit a day high of 3.33 and day low of 3.26. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Merrimack Pharma stock price history, gives the entire historical data for MACK stock.